Cargando…
A transient amphipathic helix in the prodomain of PCSK9 facilitates binding to low-density lipoprotein particles
Proprotein convertase subtilisin/kexin type-9 (PCSK9) is a ligand of low-density lipoprotein (LDL) receptor (LDLR) that promotes LDLR degradation in late endosomes/lysosomes. In human plasma, 30–40% of PCSK9 is bound to LDL particles; however, the physiological significance of this interaction remai...
Autores principales: | Sarkar, Samantha K., Foo, Alexander C. Y., Matyas, Angela, Asikhia, Ikhuosho, Kosenko, Tanja, Goto, Natalie K., Vergara-Jaque, Ariela, Lagace, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039556/ https://www.ncbi.nlm.nih.gov/pubmed/31949048 http://dx.doi.org/10.1074/jbc.RA119.010221 |
Ejemplares similares
-
Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding
por: Sarkar, Samantha K., et al.
Publicado: (2022) -
Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation
por: Kosenko, Tanja, et al.
Publicado: (2013) -
Mechanisms Responsible for the Compositional Heterogeneity of Nascent High Density Lipoprotein
por: Lund-Katz, Sissel, et al.
Publicado: (2013) -
Serum lipoprotein–derived fatty acids regulate hypoxia-inducible factor
por: Shao, Wei, et al.
Publicado: (2021) -
ANGPTL4 sensitizes lipoprotein lipase to PCSK3 cleavage by catalyzing its unfolding
por: Lund Winther, Anne-Marie, et al.
Publicado: (2021)